Dual-energy CT lung perfusion characteristics in pulmonary arterial hypertension (PAH) and pulmonary veno-occlusive disease and/or pulmonary capillary hemangiomatosis (PVOD/PCH): preliminary experience in 63 patients.

MLA

Lefebvre, Briac, et al. “Dual-Energy CT Lung Perfusion Characteristics in Pulmonary Arterial Hypertension (PAH) and Pulmonary Veno-Occlusive Disease and/or Pulmonary Capillary Hemangiomatosis (PVOD/PCH): Preliminary Experience in 63 Patients.” European Radiology, vol. 32, no. 7, July 2022, pp. 4574–86. EBSCOhost, https://doi.org/10.1007/s00330-022-08577-x.

APA

Lefebvre, B., Kyheng, M., Giordano, J., Lamblin, N., de Groote, P., Fertin, M., Delobelle, M., Perez, T., Faivre, J.-B., Remy, J., Duhamel, A., & Remy-Jardin, M. (2022). Dual-energy CT lung perfusion characteristics in pulmonary arterial hypertension (PAH) and pulmonary veno-occlusive disease and/or pulmonary capillary hemangiomatosis (PVOD/PCH): preliminary experience in 63 patients. European Radiology, 32(7), 4574–4586. https://doi.org/10.1007/s00330-022-08577-x

Chicago

Lefebvre, Briac, Maeva Kyheng, Jessica Giordano, Nicolas Lamblin, Pascal de Groote, Marie Fertin, Marie Delobelle, et al. 2022. “Dual-Energy CT Lung Perfusion Characteristics in Pulmonary Arterial Hypertension (PAH) and Pulmonary Veno-Occlusive Disease and/or Pulmonary Capillary Hemangiomatosis (PVOD/PCH): Preliminary Experience in 63 Patients.” European Radiology 32 (7): 4574–86. doi:10.1007/s00330-022-08577-x.